Effectiveness of Standardized Respiratory Physiotherapy in Primary Care

NCT01152762 | Unknown

• 1 other identifier: P07/42
• Study Type: interventional
• Target: 205
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is a very important public health problem and one of the most common lung diseases in the world, with repercussions on mortality and high economic costs. The World Health Organization estimates that COPD is the fifth most common disease in the world and the fourth leading cause of death. It is expected to grow in prevalence and mortality over the coming decades; it is estimated that in 2020, it will be the third most common cause of death worldwide. Primary care is the main ambit in the management of these patients, in fact, it is where most patients with COPD are visited. However, a high proportion of these patients only receive chest physiotherapy treatment in hospitals, and the implementation of this kind of treatment in primary care is still very uncommon. Hypothesis: There is effectiveness on the quality of life and various predictive factors of mortality (BODE index, six-minute walk distance, FEV1, dyspnea, and body mass index) and the economic impact of a Standardized Respiratory Physiotherapy program conducted in Primary Care (FREAP) in patients with moderate COPD at 6 months after its implementation.

Conditions

COPD

Keywords

Physiotherapy, COPD, effectiveness, primary care

Outcome Measures

Primary Outcomes (1)

• St. George's Respiratory Questionnaire

  Quality of life Questionnaire

  Six months

Secondary Outcomes (1)

• BODE index

  Six months

Study Arms (1)

Standardized Respiratory Physiotherapy

EXPERIMENTAL

Standardized Respiratory Physiotherapy is the intervention in all selected patients

Procedure: Standardized Respiratory Physiotherapy

Interventions

Standardized Respiratory Physiotherapy PROCEDURE

Standardized Respiratory Physiotherapy during 6 months

Standardized Respiratory Physiotherapy

Eligibility Criteria

• Age: 40 Years - 74 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Mild COPD diagnostic by GOLD criteria.
• Absence of contraindications for walk tests and training.
• Disponibility.
• Age between 40 and 74 years old.

You may not qualify if:

• Patients with treatment of oxygen or domiciliary oxygen therapy.
• Communication deficience(dementia, terminal illness, illiteracy).
• Informed consent not available.

Sponsors & Collaborators

• Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina: lead

Study Sites (1)

Catalan Health Institute

Reus, Tarragona, 43202, Spain

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Maria Montserrat Ingles Novell

  Catalan Institute of Health

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: June 28, 2010
• First Posted: June 29, 2010
• Study Start: September 1, 2007
• Primary Completion: July 1, 2008
• Study Completion: July 1, 2010
• Last Updated: June 29, 2010

Record last verified: 2010-06

Locations

ES (1)